Calprotectin in Chronic Prosthetic Joint Infection
Synovial Fluid Calprotectin Lateral Flow Test for the Diagnosis of Prosthetic Joint Infection
1 other identifier
observational
500
1 country
1
Brief Summary
A bacterial infection of an artificial joint is a serious complication that often requires additional surgery to exchange the arthroplasty. It is also difficult to recognize an infected joint, as the symptoms caused by the infection are very similar to those of other problems with arthroplasties, such as loosening of the implant. To improve the ability to diagnose prosthetic joint infections, this study compares the levels of calprotectin, a specific inflammatory protein, in the joint fluid of infected joints and joints with other complications. The underlying hypothesis is that the level of calprotectin in infected joints is significantly higher, thus facilitating the diagnosis of prosthetic joint infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 19, 2021
CompletedFirst Posted
Study publicly available on registry
September 29, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 29, 2021
September 1, 2021
4.8 years
September 19, 2021
September 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of synovial fluid calprotectin
The level of synovial fluid calprotectin measured in joint fluid aspirate as a diagnostic test for prosthetic joint infection. The accuracy is calculated by comparing its results with the International Consensus Meeting (ICM) on prosthetic joint infection criteria of 2018.
Intraoperatively
Study Arms (2)
PJI
Patients with septic arthroplasty failure
Aseptic
Patients with aseptic causes of arthroplasty failure
Interventions
Semiquantitative point of care photometric assay for the calprotectin level in joint fluid aspirate
Eligibility Criteria
Patients with painful or failed arthroplasty of the hip or knee joint scheduled for partial or complete arthroplasty exchange.
You may qualify if:
- scheduled arthroplasty exchange for any of the following reasons:
- infection
- loosening
- instability
- malalignment
- periprosthetic fracture
You may not qualify if:
- acute prosthetic joint infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Orthopedics and Sports Orthopedics, Klinikum rechts der Isar, Technical University Munich
Munich, Bavaria, 81675, Germany
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 19, 2021
First Posted
September 29, 2021
Study Start
March 1, 2019
Primary Completion
December 31, 2023
Study Completion
December 31, 2025
Last Updated
September 29, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share